Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Mannich Base PIP-199 Is a Chemically Unstable Pan-Assay Interference Compound.
Wu X, Krishna Sudhakar H, Alcock LJ, Lau YH. Wu X, et al. J Med Chem. 2023 Aug 24;66(16):11271-11281. doi: 10.1021/acs.jmedchem.3c00674. Epub 2023 Aug 9. J Med Chem. 2023. PMID: 37555818
Mannich base PIP-199 is the only reported small-molecule inhibitor of the Fanconi anemia complementation group M-RecQ-mediated genome instability protein (FANCM-RMI), a protein-protein interaction that governs genome instability in the genetic d …
Mannich base PIP-199 is the only reported small-molecule inhibitor of the Fanconi anemia complementation group …
Diagnostic significance of stromal changes in biopsies of prostate adenocarcinoma.
Dzaparidze G, Kazachonok D, Gvozdkov A, Taelma H, Laht K, Minajeva A. Dzaparidze G, et al. Pathol Res Pract. 2021 Jun;222:153436. doi: 10.1016/j.prp.2021.153436. Epub 2021 Apr 8. Pathol Res Pract. 2021. PMID: 33857855
The research aims to evaluate the potential of stromal changes as a supplementary tool to predict the presence of higher grade carcinomas in the prostate using Masson's trichrome and Fanconi anemia complementation group M (FANCM) antibody …
The research aims to evaluate the potential of stromal changes as a supplementary tool to predict the presence of higher grade carcin …
Prevalence of FANCM germline variants in BRCA1/2 negative breast and/or ovarian cancer patients from Pakistan.
Rashid MU, Muhammad N, Shehzad U, Khan FA, Loya A, Hamann U. Rashid MU, et al. Fam Cancer. 2023 Jan;22(1):31-41. doi: 10.1007/s10689-022-00304-1. Epub 2022 Jul 8. Fam Cancer. 2023. PMID: 35802266
The Fanconi anemia complementation group M (FANCM) gene is a potential candidate for breast/ovarian cancer susceptibility in European populations. ...Based on in silico and RNA analyses, p.V1857M and p.K1780delinsNGIT were predicted as va …
The Fanconi anemia complementation group M (FANCM) gene is a potential candidate for breast/ovarian cance …